- Pharmaceutical companies
- Takeda
Takeda
Phone: +81 3-3278-2111
Native name | 武田薬品工業株式会社 |
---|---|
Romanized name | Takeda Yakuhin Kōgyō kabushiki gaisha |
Formerly | Chobei Takeda & Co., Ltd. (1925-1943) Takeda Pharmaceutical Industries, Ltd. (English name only 1943-1961) Takeda Chemical Industries, Ltd. (English name only 1961-2004) |
Type | Public KK |
Traded as | |
Industry | Pharmaceuticals |
Founded | Doshomachi, Osaka, Japan (June 12, 1781 (1781-06-12)) |
Founder | Chobei Takeda I |
Headquarters | Nihonbashi, Chuo, Tokyo, Japan |
Key people | Yasuchika Hasegawa (Chairman of the Board) Christophe Weber (President & CEO) |
Revenue | ¥1,770,531 million (FY 2018) |
Operating income | ¥241,789 million (FY 2018) |
Net income | ¥186,886 million (FY 2012) |
Total assets | ¥4,106,463 billion (FY 2018) |
Total equity | ¥1,997,424 billion (FY 2018) |
Owner | Nippon Life (2.24%),
BNY Mellon(5.39%) JPMorgan Chase(3.50%) State Street Corporation(1.50%) |
Number of employees | 49,578 (2019)
(18,378) in United States (5,350) in Japan |
Website | takeda.com (Global website) |
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan. We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care for more people globally.
For detailed contact information visit location pages below.
Takeda's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Takeda
-
Takeda아직 모집하지 않음드라베 증후군(DS) | 레녹스-가스토 증후군(LGS)
-
Takeda아직 모집하지 않음
-
Takeda모병판상형 건선미국, 캐나다, 불가리아, 헝가리
-
Takeda모병드라베 증후군(DS) | 레녹스-가스토 증후군(LGS)스페인